| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | MASP1 CDHR2 CDHR3 CDH23 ADGRV1 DYSF TENM2 RYR2 STAB1 HMCN2 PCDHGB6 PCDHGA1 PCDHB13 PCDHB12 PCDHB8 PCDHA7 RAB44 HMCN1 SUSD1 VCAN LRP2 PCDH1 CDH9 | 1.19e-05 | 749 | 223 | 23 | GO:0005509 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | RAB11B CDHR2 CDHR3 OBSCN CDH23 TENM2 FASN PTPRD PTPRF PTPRH IGSF9 NPHS1 FN1 RPSA CORO1B CRKL NUMB TNXB CDH9 | 4.59e-05 | 599 | 223 | 19 | GO:0050839 |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.24e-04 | 2 | 223 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.24e-04 | 2 | 223 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.72e-04 | 188 | 223 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 3.62e-04 | 13 | 223 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 3.70e-04 | 3 | 223 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | procollagen glucosyltransferase activity | 3.70e-04 | 3 | 223 | 2 | GO:0033823 | |
| GeneOntologyMolecularFunction | procollagen-lysine 5-dioxygenase activity | 3.70e-04 | 3 | 223 | 2 | GO:0008475 | |
| GeneOntologyMolecularFunction | peptidyl-lysine 5-dioxygenase activity | 7.34e-04 | 4 | 223 | 2 | GO:0070815 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 8.32e-04 | 17 | 223 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 8.32e-04 | 17 | 223 | 3 | GO:0019198 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDHR2 CDHR3 CDH23 HMCN2 PTPRF IGSF9 SDK2 PCDHGB6 PCDHGA1 PCDHB13 PCDHB12 PCDHB8 PCDHA7 HMCN1 ROBO1 ROBO2 PCDH1 CDH9 | 1.99e-12 | 187 | 222 | 18 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CDHR2 CDHR3 CDH23 TENM2 HMCN2 PTPRD PTPRF IGSF9 SDK2 PCDHGB6 PCDHGA1 PCDHB13 PCDHB12 PCDHB8 PCDHA7 HMCN1 ROBO1 ROBO2 MDGA1 PCDH1 CDH9 | 2.89e-11 | 313 | 222 | 21 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB4 EPHB6 CDHR2 HLA-DPA1 CDHR3 CDH23 ADGRV1 TENM2 FCHO1 ARID1B HMCN2 PTPRD PTPRF IGSF9 NPHS1 SDK2 PCDHGB6 PCDHGA1 PCDHB13 PCDHB12 PCDHB8 EPB41L5 RAPGEF1 PCDHA7 RPSA CR1 HMCN1 ROBO1 ROBO2 MDGA1 PCDH1 TNXB CDH9 EP300 | 1.66e-08 | 1077 | 222 | 34 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell junction assembly | CDHR3 ACVRL1 PTPRD IQSEC1 CRB3 NPHS1 SDK2 FN1 PCDHB13 PCDHB8 EPB41L5 RAPGEF1 CRKL SIPA1L1 LINGO4 NUMB ROBO1 ROBO2 MDGA1 CDH9 | 3.80e-06 | 569 | 222 | 20 | GO:0034329 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 2.19e-05 | 53 | 222 | 6 | GO:0016339 | |
| GeneOntologyBiologicalProcess | heart development | EPHB4 XIRP1 ACACB SPEG MBD1 NACA ACVRL1 RYR2 EOMES SALL1 HECTD1 FN1 OBSL1 PCDHA7 CRKL VCAN LRP2 ROBO1 ROBO2 MYOCD ENG EP300 | 2.46e-05 | 757 | 222 | 22 | GO:0007507 |
| GeneOntologyBiologicalProcess | aorta development | 2.48e-05 | 80 | 222 | 7 | GO:0035904 | |
| GeneOntologyBiologicalProcess | synapse assembly | PTPRD IQSEC1 SDK2 PCDHB13 PCDHB8 CRKL SIPA1L1 LINGO4 NUMB ROBO1 ROBO2 MDGA1 CDH9 | 3.14e-05 | 308 | 222 | 13 | GO:0007416 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | MBD1 PARP6 CLCN2 PTPRD PTPRF PITX3 IQSEC1 FN1 OBSL1 APPL2 VCAN LINGO4 LRP2 NUMB ROBO1 ROBO2 MDGA1 ULK2 EP300 | 4.96e-05 | 625 | 222 | 19 | GO:0051960 |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 6.39e-05 | 161 | 222 | 9 | GO:0003231 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB6 CDHR3 CDH23 PALMD TENM2 PARP6 HMCN2 PTPRD PTPRF IGSF9 STRC STRCP1 FN1 OBSL1 EPB41L5 FRYL CORO1B LATS1 SIPA1L1 TTL LRP2 NUMB ROBO1 ROBO2 ULK2 CDH9 EP300 ZMYM6 | 8.89e-05 | 1194 | 222 | 28 | GO:0000902 |
| GeneOntologyBiologicalProcess | artery development | 9.82e-05 | 133 | 222 | 8 | GO:0060840 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 9.85e-05 | 9 | 222 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | negative regulation of negative chemotaxis | 1.15e-04 | 2 | 222 | 2 | GO:0050925 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 1.26e-04 | 103 | 222 | 7 | GO:0048814 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB6 CDH23 ADGRV1 TENM2 PARP6 ARID1B HMCN2 PTPRD PTPRF IQSEC1 IGSF9 STRC STRCP1 FN1 OBSL1 RAPGEF1 FRYL CREBBP CRKL SIPA1L1 TTL LRP2 NUMB ROBO1 ROBO2 ULK2 TNXB EP300 OTOG | 1.28e-04 | 1285 | 222 | 29 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | ACVRL1 PTPRD IQSEC1 CRB3 EPB41L5 RAPGEF1 SIPA1L1 LINGO4 NUMB ROBO1 ROBO2 MDGA1 | 1.39e-04 | 309 | 222 | 12 | GO:1901888 |
| GeneOntologyBiologicalProcess | cell junction organization | CDHR3 ACVRL1 HMCN2 PTPRD PTPRF IQSEC1 CRB3 IGSF9 NPHS1 SDK2 FN1 PCDHB13 PCDHB8 EPB41L5 RAPGEF1 CRKL SIPA1L1 LINGO4 NUMB ROBO1 ROBO2 PRRT1 MDGA1 CDH9 | 1.40e-04 | 974 | 222 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | MBD1 PARP6 CLCN2 PTPRD PTPRF PITX3 FN1 OBSL1 APPL2 VCAN LRP2 NUMB ROBO1 ROBO2 ULK2 EP300 | 1.54e-04 | 515 | 222 | 16 | GO:0050767 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB6 CDH23 TENM2 PARP6 HMCN2 PTPRD PTPRF IGSF9 STRC STRCP1 FN1 OBSL1 SIPA1L1 TTL LRP2 NUMB ROBO1 ROBO2 ULK2 EP300 | 1.80e-04 | 748 | 222 | 20 | GO:0048667 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | PARP6 CLCN2 PTPRD PTPRF IQSEC1 FN1 OBSL1 VCAN LINGO4 LRP2 NUMB ROBO1 ROBO2 EP300 | 1.86e-04 | 418 | 222 | 14 | GO:0051962 |
| GeneOntologyBiologicalProcess | outflow tract septum morphogenesis | 2.18e-04 | 28 | 222 | 4 | GO:0003148 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 2.26e-04 | 150 | 222 | 8 | GO:0050773 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell stereocilium organization | 2.60e-04 | 53 | 222 | 5 | GO:0060122 | |
| GeneOntologyBiologicalProcess | dendrite development | PARP6 ARID1B PTPRD PTPRF IQSEC1 IGSF9 OBSL1 CREBBP CRKL SIPA1L1 NUMB ROBO1 | 2.92e-04 | 335 | 222 | 12 | GO:0016358 |
| GeneOntologyBiologicalProcess | positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis | 3.44e-04 | 3 | 222 | 2 | GO:1905451 | |
| GeneOntologyCellularComponent | extracellular matrix | IL16 COL6A5 COL22A1 FREM1 MFAP1 FCGBP HMCN2 PZP PLOD1 NPHS1 COL12A1 FN1 COL20A1 RPSA ITIH5 HMCN1 VCAN LINGO4 SDC3 CTSD TNXB OTOG | 3.78e-06 | 656 | 230 | 22 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | IL16 COL6A5 COL22A1 FREM1 MFAP1 FCGBP HMCN2 PZP PLOD1 NPHS1 COL12A1 FN1 COL20A1 RPSA ITIH5 HMCN1 VCAN LINGO4 SDC3 CTSD TNXB OTOG | 3.97e-06 | 658 | 230 | 22 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | IL16 COL6A5 COL22A1 FREM1 MFAP1 HMCN2 PZP PLOD1 NPHS1 COL12A1 FN1 COL20A1 RPSA ITIH5 HMCN1 VCAN SDC3 CTSD TNXB | 7.00e-06 | 530 | 230 | 19 | GO:0062023 |
| GeneOntologyCellularComponent | stereocilium tip | 8.94e-05 | 22 | 230 | 4 | GO:0032426 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 1.05e-04 | 9 | 230 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | A band | 2.63e-04 | 52 | 230 | 5 | GO:0031672 | |
| GeneOntologyCellularComponent | non-motile cilium | 3.33e-04 | 196 | 230 | 9 | GO:0097730 | |
| GeneOntologyCellularComponent | M band | 3.56e-04 | 31 | 230 | 4 | GO:0031430 | |
| GeneOntologyCellularComponent | nuclear body | IL16 HIVEP1 MRPL44 MBD1 OBSCN ZNF395 CMYA5 TENM2 PTPRH CIITA SIMC1 HECTD1 NPAT CREBBP RFWD3 EIF2D ARNT CSF1 MDC1 SETBP1 ENG NBR1 | 4.28e-04 | 903 | 230 | 22 | GO:0016604 |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 4.38e-04 | 14 | 230 | 3 | GO:0097732 | |
| GeneOntologyCellularComponent | kinocilium | 4.38e-04 | 14 | 230 | 3 | GO:0060091 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 4.38e-04 | 14 | 230 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | Rab-protein geranylgeranyltransferase complex | 7.13e-04 | 4 | 230 | 2 | GO:0005968 | |
| GeneOntologyCellularComponent | stereocilium | 9.79e-04 | 69 | 230 | 5 | GO:0032420 | |
| MousePheno | perimembraneous ventricular septal defect | 2.30e-05 | 92 | 179 | 8 | MP:0010418 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 2.49e-05 | 93 | 179 | 8 | MP:0008823 | |
| Domain | fn3 | EPHB4 EPHB6 SPEG OBSCN CMYA5 IGSF22 PTPRD PTPRF PTPRH IGSF9 NPHS1 SDK2 COL12A1 FN1 COL20A1 OBSL1 ROBO1 ROBO2 TNXB | 5.63e-14 | 162 | 219 | 19 | PF00041 |
| Domain | FN3 | EPHB4 EPHB6 SPEG OBSCN CMYA5 IGSF22 PTPRD PTPRF PTPRH IGSF9 NPHS1 SDK2 COL12A1 FN1 COL20A1 OBSL1 ROBO1 ROBO2 MDGA1 TNXB | 5.76e-14 | 185 | 219 | 20 | SM00060 |
| Domain | FN3 | EPHB4 EPHB6 SPEG OBSCN CMYA5 IGSF22 PTPRD PTPRF PTPRH IGSF9 NPHS1 SDK2 COL12A1 FN1 COL20A1 OBSL1 ROBO1 ROBO2 MDGA1 TNXB | 2.32e-13 | 199 | 219 | 20 | PS50853 |
| Domain | FN3_dom | EPHB4 EPHB6 SPEG OBSCN CMYA5 IGSF22 PTPRD PTPRF PTPRH IGSF9 NPHS1 SDK2 COL12A1 FN1 COL20A1 OBSL1 ROBO1 ROBO2 MDGA1 TNXB | 5.86e-13 | 209 | 219 | 20 | IPR003961 |
| Domain | Ig_I-set | SPEG OBSCN IGSF10 IGSF22 HMCN2 PTPRD PTPRF IGSF9 NPHS1 SDK2 OBSL1 HMCN1 LINGO4 ROBO1 ROBO2 MDGA1 | 8.79e-10 | 190 | 219 | 16 | IPR013098 |
| Domain | I-set | SPEG OBSCN IGSF10 IGSF22 HMCN2 PTPRD PTPRF IGSF9 NPHS1 SDK2 OBSL1 HMCN1 LINGO4 ROBO1 ROBO2 MDGA1 | 8.79e-10 | 190 | 219 | 16 | PF07679 |
| Domain | Ig-like_fold | EPHB4 EPHB6 HLA-DPA1 SPEG OBSCN CMYA5 IGSF10 IGSF22 HMCN2 PTPRD PTPRF PTPRH NOMO2 IGSF9 NPHS1 SDK2 COL12A1 FN1 COL20A1 OBSL1 FCRLA NOMO1 HMCN1 VCAN LINGO4 ROBO1 ROBO2 MDGA1 TNXB NOMO3 | 1.04e-09 | 706 | 219 | 30 | IPR013783 |
| Domain | - | EPHB4 EPHB6 HLA-DPA1 SPEG OBSCN CMYA5 IGSF10 IGSF22 PTPRD PTPRF NOMO2 IGSF9 NPHS1 SDK2 COL12A1 FN1 COL20A1 OBSL1 FCRLA NOMO1 HMCN1 VCAN LINGO4 ROBO1 ROBO2 MDGA1 TNXB NOMO3 | 4.51e-09 | 663 | 219 | 28 | 2.60.40.10 |
| Domain | Cadherin | CDHR2 CDHR3 CDH23 FREM1 PCDHGB6 PCDHGA1 PCDHB13 PCDHB12 PCDHB8 PCDHA7 PCDH1 CDH9 | 1.43e-08 | 118 | 219 | 12 | IPR002126 |
| Domain | IGc2 | SPEG OBSCN IGSF10 IGSF22 HMCN2 PTPRD PTPRF IGSF9 NPHS1 SDK2 OBSL1 HMCN1 LINGO4 ROBO1 ROBO2 MDGA1 | 1.88e-08 | 235 | 219 | 16 | SM00408 |
| Domain | Ig_sub2 | SPEG OBSCN IGSF10 IGSF22 HMCN2 PTPRD PTPRF IGSF9 NPHS1 SDK2 OBSL1 HMCN1 LINGO4 ROBO1 ROBO2 MDGA1 | 1.88e-08 | 235 | 219 | 16 | IPR003598 |
| Domain | CADHERIN_1 | CDHR2 CDHR3 CDH23 PCDHGB6 PCDHGA1 PCDHB13 PCDHB12 PCDHB8 PCDHA7 PCDH1 CDH9 | 9.15e-08 | 113 | 219 | 11 | PS00232 |
| Domain | Cadherin | CDHR2 CDHR3 CDH23 PCDHGB6 PCDHGA1 PCDHB13 PCDHB12 PCDHB8 PCDHA7 PCDH1 CDH9 | 9.15e-08 | 113 | 219 | 11 | PF00028 |
| Domain | CADHERIN_2 | CDHR2 CDHR3 CDH23 PCDHGB6 PCDHGA1 PCDHB13 PCDHB12 PCDHB8 PCDHA7 PCDH1 CDH9 | 1.00e-07 | 114 | 219 | 11 | PS50268 |
| Domain | - | CDHR2 CDHR3 CDH23 PCDHGB6 PCDHGA1 PCDHB13 PCDHB12 PCDHB8 PCDHA7 PCDH1 CDH9 | 1.00e-07 | 114 | 219 | 11 | 2.60.40.60 |
| Domain | CA | CDHR2 CDHR3 CDH23 PCDHGB6 PCDHGA1 PCDHB13 PCDHB12 PCDHB8 PCDHA7 PCDH1 CDH9 | 1.10e-07 | 115 | 219 | 11 | SM00112 |
| Domain | Cadherin-like | CDHR2 CDHR3 CDH23 PCDHGB6 PCDHGA1 PCDHB13 PCDHB12 PCDHB8 PCDHA7 PCDH1 CDH9 | 1.20e-07 | 116 | 219 | 11 | IPR015919 |
| Domain | Cadherin_CS | CDHR2 CDH23 PCDHGB6 PCDHGA1 PCDHB13 PCDHB12 PCDHB8 PCDHA7 PCDH1 CDH9 | 6.20e-07 | 109 | 219 | 10 | IPR020894 |
| Domain | IG | SPEG OBSCN IGSF10 IGSF22 HMCN2 PTPRD PTPRF IGSF9 NPHS1 SDK2 OBSL1 FCRLA HMCN1 VCAN LINGO4 ROBO1 ROBO2 MDGA1 | 2.54e-06 | 421 | 219 | 18 | SM00409 |
| Domain | Ig_sub | SPEG OBSCN IGSF10 IGSF22 HMCN2 PTPRD PTPRF IGSF9 NPHS1 SDK2 OBSL1 FCRLA HMCN1 VCAN LINGO4 ROBO1 ROBO2 MDGA1 | 2.54e-06 | 421 | 219 | 18 | IPR003599 |
| Domain | IG_LIKE | HLA-DPA1 SPEG OBSCN IGSF10 IGSF22 HMCN2 PTPRD PTPRF IGSF9 NPHS1 SDK2 OBSL1 FCRLA HMCN1 VCAN LINGO4 ROBO1 ROBO2 MDGA1 | 5.66e-06 | 491 | 219 | 19 | PS50835 |
| Domain | DUF2012 | 6.31e-06 | 4 | 219 | 3 | PF09430 | |
| Domain | LRRC37AB_C | 6.31e-06 | 4 | 219 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 6.31e-06 | 4 | 219 | 3 | PF14914 | |
| Domain | DUF2012 | 6.31e-06 | 4 | 219 | 3 | IPR019008 | |
| Domain | LRRC37_N | 6.31e-06 | 4 | 219 | 3 | IPR032754 | |
| Domain | LRRC37 | 6.31e-06 | 4 | 219 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 6.31e-06 | 4 | 219 | 3 | IPR015753 | |
| Domain | Ig-like_dom | HLA-DPA1 SPEG OBSCN IGSF10 IGSF22 HMCN2 PTPRD PTPRF IGSF9 NPHS1 SDK2 OBSL1 FCRLA HMCN1 VCAN LINGO4 ROBO1 ROBO2 MDGA1 | 7.97e-06 | 503 | 219 | 19 | IPR007110 |
| Domain | Cadherin_C | 8.95e-06 | 42 | 219 | 6 | IPR032455 | |
| Domain | Cadherin_C_2 | 8.95e-06 | 42 | 219 | 6 | PF16492 | |
| Domain | Cadherin_2 | 1.08e-05 | 65 | 219 | 7 | PF08266 | |
| Domain | Cadherin_N | 1.08e-05 | 65 | 219 | 7 | IPR013164 | |
| Domain | TIL_dom | 1.68e-05 | 14 | 219 | 4 | IPR002919 | |
| Domain | VWF_A | 2.16e-05 | 99 | 219 | 8 | IPR002035 | |
| Domain | Nuc_rcpt_coact | 3.10e-05 | 6 | 219 | 3 | IPR009110 | |
| Domain | CarboxyPept-like_regulatory | 3.88e-05 | 17 | 219 | 4 | IPR008969 | |
| Domain | VWFA | 5.00e-05 | 82 | 219 | 7 | PS50234 | |
| Domain | VWA | 5.83e-05 | 84 | 219 | 7 | SM00327 | |
| Domain | Carb-bd-like_fold | 8.53e-05 | 8 | 219 | 3 | IPR013784 | |
| Domain | EGF_CA | 9.63e-05 | 122 | 219 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.08e-04 | 124 | 219 | 8 | IPR001881 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.37e-04 | 2 | 219 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 1.37e-04 | 2 | 219 | 2 | SM00551 | |
| Domain | - | 1.37e-04 | 2 | 219 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.37e-04 | 2 | 219 | 2 | IPR010303 | |
| Domain | - | 1.37e-04 | 2 | 219 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.37e-04 | 2 | 219 | 2 | PF09030 | |
| Domain | zf-TAZ | 1.37e-04 | 2 | 219 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.37e-04 | 2 | 219 | 2 | PS50134 | |
| Domain | KAT11 | 1.37e-04 | 2 | 219 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.37e-04 | 2 | 219 | 2 | IPR000197 | |
| Domain | KIX | 1.37e-04 | 2 | 219 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 1.37e-04 | 2 | 219 | 2 | PF08214 | |
| Domain | KIX | 1.37e-04 | 2 | 219 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 1.37e-04 | 2 | 219 | 2 | IPR031162 | |
| Domain | DUF902 | 1.37e-04 | 2 | 219 | 2 | PF06001 | |
| Domain | Rab_escort | 1.37e-04 | 2 | 219 | 2 | IPR001738 | |
| Domain | - | 1.37e-04 | 2 | 219 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.37e-04 | 2 | 219 | 2 | IPR013178 | |
| Domain | KIX_dom | 1.37e-04 | 2 | 219 | 2 | IPR003101 | |
| Domain | CBP_P300_HAT | 1.37e-04 | 2 | 219 | 2 | PS51727 | |
| Domain | EGF-like_dom | MASP1 TENM2 STAB1 FCGBP HMCN2 HMCN1 SUSD1 VCAN LRP2 TNXB OTOG | 1.79e-04 | 249 | 219 | 11 | IPR000742 |
| Domain | - | 2.31e-04 | 74 | 219 | 6 | 3.40.50.410 | |
| Domain | GFP-like | 2.45e-04 | 11 | 219 | 3 | IPR023413 | |
| Domain | - | 2.45e-04 | 11 | 219 | 3 | 2.40.155.10 | |
| Domain | EGF-like_CS | EPHB4 MASP1 TENM2 STAB1 HMCN2 FN1 HMCN1 SUSD1 VCAN LRP2 TNXB | 2.69e-04 | 261 | 219 | 11 | IPR013032 |
| Domain | C8 | 3.24e-04 | 12 | 219 | 3 | PF08742 | |
| Domain | TIL | 3.24e-04 | 12 | 219 | 3 | PF01826 | |
| Domain | AKAP_110_C | 4.07e-04 | 3 | 219 | 2 | IPR018292 | |
| Domain | TACC | 4.07e-04 | 3 | 219 | 2 | PF05010 | |
| Domain | Procol_lys_dOase | 4.07e-04 | 3 | 219 | 2 | IPR001006 | |
| Domain | LYS_HYDROXYLASE | 4.07e-04 | 3 | 219 | 2 | PS01325 | |
| Domain | TACC | 4.07e-04 | 3 | 219 | 2 | IPR007707 | |
| Domain | CarboxyPept_regulatory_dom | 4.17e-04 | 13 | 219 | 3 | IPR014766 | |
| Domain | Unchr_dom_Cys-rich | 4.17e-04 | 13 | 219 | 3 | IPR014853 | |
| Domain | C8 | 4.17e-04 | 13 | 219 | 3 | SM00832 | |
| Domain | - | 4.17e-04 | 13 | 219 | 3 | 2.60.40.1120 | |
| Domain | EGF_3 | 4.72e-04 | 235 | 219 | 10 | PS50026 | |
| Domain | VWA | 4.97e-04 | 56 | 219 | 5 | PF00092 | |
| Domain | Growth_fac_rcpt_ | 5.17e-04 | 156 | 219 | 8 | IPR009030 | |
| Domain | VWF_type-D | 7.96e-04 | 16 | 219 | 3 | IPR001846 | |
| Domain | VWFD | 7.96e-04 | 16 | 219 | 3 | PS51233 | |
| Domain | VWD | 7.96e-04 | 16 | 219 | 3 | SM00216 | |
| Domain | VWD | 7.96e-04 | 16 | 219 | 3 | PF00094 | |
| Domain | Neural_cell_adh | 8.09e-04 | 4 | 219 | 2 | IPR009138 | |
| Domain | G2F | 8.09e-04 | 4 | 219 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 8.09e-04 | 4 | 219 | 2 | PS50993 | |
| Domain | GDI | 8.09e-04 | 4 | 219 | 2 | PF00996 | |
| Domain | GFP | 8.09e-04 | 4 | 219 | 2 | IPR009017 | |
| Domain | SPHK1-interactor_AKAP_110 | 8.09e-04 | 4 | 219 | 2 | IPR008382 | |
| Domain | GDP_dissociation_inhibitor | 8.09e-04 | 4 | 219 | 2 | IPR018203 | |
| Domain | AKAP_110 | 8.09e-04 | 4 | 219 | 2 | PF05716 | |
| Domain | G2_nidogen/fibulin_G2F | 8.09e-04 | 4 | 219 | 2 | IPR006605 | |
| Domain | EGF_1 | 8.87e-04 | 255 | 219 | 10 | PS00022 | |
| Domain | EGF_Ca-bd_CS | 9.88e-04 | 97 | 219 | 6 | IPR018097 | |
| Domain | EGF_CA | 1.10e-03 | 99 | 219 | 6 | PS01187 | |
| Domain | ZF_ZZ_2 | 1.14e-03 | 18 | 219 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.14e-03 | 18 | 219 | 3 | PS01357 | |
| Domain | ZZ | 1.14e-03 | 18 | 219 | 3 | PF00569 | |
| Pathway | WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS | 3.42e-05 | 86 | 149 | 7 | M39375 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.34e-05 | 61 | 149 | 6 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 7.40e-05 | 67 | 149 | 6 | M26999 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A5 COL22A1 PLOD1 PLOD2 COL12A1 FN1 COL20A1 VCAN SDC3 CTSD TNXB | 9.29e-05 | 258 | 149 | 11 | MM14572 |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.50e-04 | 76 | 149 | 6 | MM14573 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.79e-04 | 11 | 149 | 3 | M26924 | |
| Pubmed | AGAP5 NACA ADGRV1 STAB1 ARID1B ATG4B TNRC6A IGSF9 MED13 SDK2 HECTD4 KIAA1549 MDC1 SETBP1 SDC3 ROBO2 AGAP9 NBR1 | 2.00e-08 | 529 | 231 | 18 | 14621295 | |
| Pubmed | KNTC1 NACA HLCS STAT2 MFAP1 ARID1B NOMO2 ANAPC1 TNRC6A TACC1 HECTD1 TUT7 EPB41L5 AKAP3 CORO1B WDR6 MDC1 MASTL ROBO1 USP54 NBR1 | 2.51e-08 | 733 | 231 | 21 | 34672954 | |
| Pubmed | 4.76e-08 | 77 | 231 | 8 | 10835267 | ||
| Pubmed | The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases. | 6.53e-08 | 7 | 231 | 4 | 14767476 | |
| Pubmed | 1.96e-07 | 167 | 231 | 10 | 22159717 | ||
| Pubmed | 2.34e-07 | 64 | 231 | 7 | 22261194 | ||
| Pubmed | 2.89e-07 | 3 | 231 | 3 | 36011023 | ||
| Pubmed | 2.89e-07 | 3 | 231 | 3 | 10748089 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 2.89e-07 | 3 | 231 | 3 | 25576386 | |
| Pubmed | KNTC1 ACACB SPICE1 ARID1B ANAPC1 TNRC6A PLOD1 HECTD1 CRTC3 KIAA1549 FRYL LATS1 SIPA1L1 USP54 PPP6R2 | 3.63e-07 | 446 | 231 | 15 | 24255178 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 SPRY2 SPEG OBSCN ZNF395 DYSF PLEKHM1 FASN SLC8B1 PTPRF TMEM132A HECTD1 MED13 PRRC2B BICRA HECTD4 RAPGEF1 RPSA FRYL CORO1B FAM83H RPAP1 ULK2 EP300 | 4.20e-07 | 1105 | 231 | 24 | 35748872 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KNTC1 HIVEP1 BCORL1 RTN3 STAT2 SALL1 NOMO2 ANAPC1 TNRC6A PRRC2B OBSL1 TACC2 CREBBP ARNT PPP6R2 ZMYM6 CDC23 | 4.98e-07 | 588 | 231 | 17 | 38580884 |
| Pubmed | IL16 MBD1 HLCS MFAP1 ZNF469 ARID1B HMCN2 ANAPC1 TNRC6A IQSEC1 PRRC2B BICRA OBSL1 KIAA1549 CREBBP PDHX FAM83H WDR6 SIPA1L1 MEPCE LRP2 USP54 EP300 CDC23 | 5.01e-07 | 1116 | 231 | 24 | 31753913 | |
| Pubmed | 6.03e-07 | 11 | 231 | 4 | 31776257 | ||
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 6.42e-07 | 74 | 231 | 7 | 10817752 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | HIVEP1 ACACB NAB2 BCORL1 ARID1B SALL1 PRRC2B BICRA CREBBP ARNT WDR6 MDC1 EP300 | 7.62e-07 | 351 | 231 | 13 | 38297188 |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.10e-06 | 80 | 231 | 7 | 10716726 | |
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 11314014 | ||
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 9660935 | ||
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 12604599 | ||
| Pubmed | SLIT2/ROBO1 signaling suppresses mTORC1 for organelle control and bacterial killing. | 1.15e-06 | 4 | 231 | 3 | 37311584 | |
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 22419166 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 1.15e-06 | 4 | 231 | 3 | 31833031 | |
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 18678383 | ||
| Pubmed | 1.15e-06 | 4 | 231 | 3 | 9267806 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ACACB HLCS PFKM NOMO2 SIMC1 TNRC6A PLOD1 PRRC2B TUT7 CORO1B PDHX CRKL FAM83H ARHGAP5 EIF2D LATS1 SIPA1L1 LRP2 USP54 PPP6R2 | 1.28e-06 | 853 | 231 | 20 | 28718761 |
| Pubmed | 1.51e-06 | 162 | 231 | 9 | 25826454 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 2.62e-06 | 91 | 231 | 7 | 28558017 | |
| Pubmed | 2.85e-06 | 175 | 231 | 9 | 28071719 | ||
| Pubmed | Stat protein transactivation domains recruit p300/CBP through widely divergent sequences. | 2.86e-06 | 5 | 231 | 3 | 10464260 | |
| Pubmed | 2.86e-06 | 5 | 231 | 3 | 9990060 | ||
| Pubmed | Cross-linking of EphB6 resulting in signal transduction and apoptosis in Jurkat cells. | 2.86e-06 | 5 | 231 | 3 | 11466354 | |
| Pubmed | 2.86e-06 | 5 | 231 | 3 | 24920589 | ||
| Pubmed | 4.61e-06 | 99 | 231 | 7 | 19730683 | ||
| Pubmed | HIVEP1 ACACB BCORL1 FASN SALL1 ANAPC1 TNRC6A TANGO6 NPAT CRKL WDR6 LRP2 CDC23 | 5.19e-06 | 418 | 231 | 13 | 34709266 | |
| Pubmed | ACACB NACA BCORL1 ANAPC1 TNRC6A PRRC2B OBSL1 MEPCE NBR1 CDC23 | 5.65e-06 | 242 | 231 | 10 | 34011540 | |
| Pubmed | EPHB6 SPRY2 MBD1 HLCS CMYA5 STAB1 PTPRD NOMO2 HECTD1 MED13 FN1 HECTD4 RTL10 OBSL1 CREBBP ZNF7 ARHGAP5 APPL2 TMEM168 SIPA1L1 LRP2 ROBO1 USP54 EP300 | 5.70e-06 | 1285 | 231 | 24 | 35914814 | |
| Pubmed | Role of CBP in regulating HIF-1-mediated activation of transcription. | 5.70e-06 | 6 | 231 | 3 | 15615775 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | SPRY2 HIVEP1 MBD1 RTN3 PLEKHM1 TASOR2 STAB1 IGSF9 FN1 RPSA FRYL TACC2 CORO1B NOMO1 SIPA1L1 | 5.96e-06 | 560 | 231 | 15 | 21653829 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 6.24e-06 | 68 | 231 | 6 | 11230163 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 8.72e-06 | 72 | 231 | 6 | 10380929 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ARID1B ANAPC1 TRMT1L PLOD1 HECTD1 PLOD2 NUP153 TUT7 HECTD4 WDR6 MDC1 USP54 CDC23 | 8.97e-06 | 440 | 231 | 13 | 34244565 |
| Pubmed | The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2. | 9.93e-06 | 7 | 231 | 3 | 15154850 | |
| Pubmed | Slit/Robo signaling modulates the proliferation of central nervous system progenitors. | 1.52e-05 | 23 | 231 | 4 | 23083737 | |
| Pubmed | Acetylation-dependent signal transduction for type I interferon receptor. | 1.58e-05 | 8 | 231 | 3 | 17923090 | |
| Pubmed | Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane. | 1.58e-05 | 8 | 231 | 3 | 21165971 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.58e-05 | 8 | 231 | 3 | 15257293 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 1.68e-05 | 218 | 231 | 9 | 33378226 | |
| Pubmed | HIVEP1 NACA IRF7 STAT2 ZBP1 IQSEC1 PRRC2B OBSL1 CREBBP EP300 | 2.19e-05 | 283 | 231 | 10 | 21903422 | |
| Pubmed | 2.36e-05 | 9 | 231 | 3 | 23834954 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 2.36e-05 | 9 | 231 | 3 | 36261522 | |
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 2.49e-05 | 128 | 231 | 7 | 25332235 | |
| Pubmed | 2.75e-05 | 130 | 231 | 7 | 12421765 | ||
| Pubmed | IL16 NACA BCORL1 MFAP1 NOMO2 CRTC3 BICRA RPSA CREBBP NOMO1 EP300 NOMO3 | 3.10e-05 | 425 | 231 | 12 | 24999758 | |
| Pubmed | 3.18e-05 | 182 | 231 | 8 | 15102471 | ||
| Pubmed | HIVEP1 ACACB MRPL44 NACA BCORL1 TMOD2 STAT2 MFAP1 ARID1B SALL1 BBX TNRC6A TRMT1L PRRC2B TANGO6 NPAT BICRA RPSA CREBBP ARNT MDC1 LRP2 USP54 EP300 | 3.21e-05 | 1429 | 231 | 24 | 35140242 | |
| Pubmed | 3.35e-05 | 10 | 231 | 3 | 21307234 | ||
| Pubmed | 3.35e-05 | 10 | 231 | 3 | 23064749 | ||
| Pubmed | 3.35e-05 | 10 | 231 | 3 | 22969705 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ACACB PEX14 TASOR2 ZNF469 SALL1 NUP153 CRTC3 BICRA LATS1 MDC1 SETBP1 NUMB | 3.47e-05 | 430 | 231 | 12 | 35044719 |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.51e-05 | 135 | 231 | 7 | 28675934 | |
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 3.81e-05 | 302 | 231 | 10 | 30561431 | |
| Pubmed | The Stratified Population Screening of Hereditary Hemorrhagic Telangiectasia. | 4.39e-05 | 2 | 231 | 2 | 30685840 | |
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 4.39e-05 | 2 | 231 | 2 | 34845315 | |
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 19729597 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 29500156 | ||
| Pubmed | Robo signaling regulates the production of cranial neural crest cells. | 4.39e-05 | 2 | 231 | 2 | 28987541 | |
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 25847705 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 16470589 | ||
| Pubmed | Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France. | 4.39e-05 | 2 | 231 | 2 | 15024723 | |
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 39287984 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 9175730 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 34968453 | ||
| Pubmed | High frequency of ENG and ALK1/ACVRL1 mutations in German HHT patients. | 4.39e-05 | 2 | 231 | 2 | 15880681 | |
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 20717166 | ||
| Pubmed | Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. | 4.39e-05 | 2 | 231 | 2 | 8848048 | |
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 17224686 | ||
| Pubmed | Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage. | 4.39e-05 | 2 | 231 | 2 | 32523017 | |
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 25893291 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 16707491 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 11559821 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 23919827 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 31597096 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 32576962 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 19822209 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 24522976 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 4.39e-05 | 2 | 231 | 2 | 21847097 | |
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 19015642 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 16179574 | ||
| Pubmed | Shear induced collateral artery growth modulated by endoglin but not by ALK1. | 4.39e-05 | 2 | 231 | 2 | 22436015 | |
| Pubmed | Experimental Characterization of the Interaction between the N-Terminal SH3 Domain of Crkl and C3G. | 4.39e-05 | 2 | 231 | 2 | 34947971 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 4.39e-05 | 2 | 231 | 2 | 34813504 | |
| Pubmed | A heart segmental defect in the anterior-posterior axis of a transgenic mutant mouse. | 4.39e-05 | 2 | 231 | 2 | 9188753 | |
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 7665159 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 20301699 | ||
| Pubmed | DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population. | 4.39e-05 | 2 | 231 | 2 | 16429404 | |
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 24639469 | ||
| Pubmed | 4.39e-05 | 2 | 231 | 2 | 37816914 | ||
| Pubmed | Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation. | 4.39e-05 | 2 | 231 | 2 | 32683896 | |
| Interaction | ASF1A interactions | HIVEP1 BCORL1 TASOR2 CDAN1 FASN ARID1B NPAT BICRA ARNT MDC1 EP300 ZMYM6 PPTC7 BRF2 | 9.56e-07 | 249 | 227 | 14 | int:ASF1A |
| Cytoband | 5q31 | 2.06e-06 | 115 | 231 | 7 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 1.46e-04 | 298 | 231 | 8 | chr5q31 | |
| Cytoband | 3q27-q28 | 1.50e-04 | 4 | 231 | 2 | 3q27-q28 | |
| Cytoband | 5q35.2 | 5.60e-04 | 32 | 231 | 3 | 5q35.2 | |
| Cytoband | 17q21.31 | 8.03e-04 | 82 | 231 | 4 | 17q21.31 | |
| Cytoband | 1p36.22 | 8.61e-04 | 37 | 231 | 3 | 1p36.22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 9.24e-04 | 147 | 231 | 5 | chr15q15 | |
| GeneFamily | Fibronectin type III domain containing | EPHB4 EPHB6 OBSCN CMYA5 IGSF22 PTPRD PTPRF PTPRH IGSF9 NPHS1 SDK2 COL12A1 FN1 COL20A1 ROBO1 ROBO2 TNXB | 1.66e-14 | 160 | 148 | 17 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | SPEG OBSCN IGSF10 IGSF22 HMCN2 PTPRD PTPRF IGSF9 SDK2 OBSL1 HMCN1 LINGO4 ROBO1 ROBO2 MDGA1 | 4.30e-12 | 161 | 148 | 15 | 593 |
| GeneFamily | Clustered protocadherins | 1.38e-05 | 64 | 148 | 6 | 20 | |
| GeneFamily | Cadherin related | 3.36e-04 | 17 | 148 | 3 | 24 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 3.36e-04 | 17 | 148 | 3 | 1291 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.01e-04 | 18 | 148 | 3 | 91 | |
| GeneFamily | Collagens | 5.39e-04 | 46 | 148 | 4 | 490 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 6.42e-04 | 21 | 148 | 3 | 813 | |
| GeneFamily | Immunoglobulin like domain containing | 1.07e-03 | 193 | 148 | 7 | 594 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.22e-03 | 57 | 148 | 4 | 1179 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.68e-03 | 29 | 148 | 3 | 396 | |
| GeneFamily | Fibulins | 1.80e-03 | 8 | 148 | 2 | 556 | |
| GeneFamily | Chloride voltage-gated channels | 2.87e-03 | 10 | 148 | 2 | 302 | |
| GeneFamily | Tubulin tyrosine ligase family | 5.68e-03 | 14 | 148 | 2 | 779 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 5.68e-03 | 14 | 148 | 2 | 1095 | |
| GeneFamily | Anaphase promoting complex |Tetratricopeptide repeat domain containing | 5.68e-03 | 14 | 148 | 2 | 402 | |
| Coexpression | NABA_MATRISOME | MASP1 IL16 COL6A5 COL22A1 ASTL FREM1 IGSF10 MFAP1 HMCN2 PZP PLOD1 PLOD2 COL12A1 FN1 COL20A1 MUC19 MUC16 ITIH5 CSF1 HMCN1 VCAN SDC3 CTSD TNXB OTOG | 2.71e-06 | 1008 | 228 | 25 | MM17056 |
| Coexpression | NABA_MATRISOME | MASP1 IL16 COL6A5 COL22A1 ASTL FREM1 IGSF10 MFAP1 HMCN2 PZP PLOD1 PLOD2 COL12A1 FN1 COL20A1 MUC19 MUC16 ITIH5 CSF1 HMCN1 VCAN SDC3 CTSD TNXB OTOG | 3.70e-06 | 1026 | 228 | 25 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | COL6A5 COL22A1 IGSF10 MFAP1 HMCN2 COL12A1 FN1 COL20A1 HMCN1 VCAN TNXB OTOG | 4.79e-06 | 270 | 228 | 12 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL6A5 COL22A1 IGSF10 MFAP1 HMCN2 COL12A1 FN1 COL20A1 HMCN1 VCAN TNXB OTOG | 5.78e-06 | 275 | 228 | 12 | M5884 |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP | 1.08e-05 | 200 | 228 | 10 | M3860 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | ZNF142 MBD1 CDH23 IRF7 DYSF PLEKHM1 STAT2 CDAN1 ATG4B SLC8B1 IQSEC1 MARCHF1 BICRA RAPGEF1 CREBBP ITIH5 WDR6 MDC1 ENG EP300 MAST3 PPTC7 | 1.52e-05 | 905 | 228 | 22 | M40865 |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | EPHB6 SPEG RYR2 PTPRD PTPRF TMEM132A IGSF9 NPHS1 COL12A1 MUC16 LRP2 MDGA1 | 2.11e-05 | 313 | 228 | 12 | M40228 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP | 3.61e-05 | 22 | 228 | 4 | M40867 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TCERG1L ADGRV1 FREM1 RYR2 CIITA TAT COL12A1 MUC19 RPSA FCRLA HMCN1 LRP2 | 1.41e-10 | 175 | 231 | 12 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | IL16 COL6A5 TENM2 FREM1 RYR2 IGSF10 PTPRD FN1 HMCN1 SETBP1 ROBO1 ROBO2 | 2.09e-10 | 181 | 231 | 12 | 9ede19228ba5c0668a9c06c915510b95585216ef |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN COL22A1 ADGRV1 FREM1 RYR2 PTPRD COL12A1 HMCN1 LRP2 ROBO1 MYOCD OTOG | 2.53e-10 | 184 | 231 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN COL22A1 ADGRV1 FREM1 RYR2 PTPRD COL12A1 HMCN1 LRP2 ROBO1 MYOCD OTOG | 2.53e-10 | 184 | 231 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN COL22A1 ADGRV1 FREM1 RYR2 PTPRD COL12A1 HMCN1 LRP2 ROBO1 MYOCD OTOG | 2.53e-10 | 184 | 231 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | COL6A5 FREM1 IGSF10 PTPRD PZP SDK2 FN1 ITIH5 VCAN SDC3 ROBO1 TNXB | 6.22e-10 | 199 | 231 | 12 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL6A5 COL22A1 ADGRV1 FREM1 RYR2 COL12A1 MUC19 HMCN1 SPHKAP LRP2 MYOCD | 8.16e-10 | 160 | 231 | 11 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL6A5 COL22A1 ADGRV1 FREM1 RYR2 COL12A1 MUC19 HMCN1 SPHKAP LRP2 MYOCD | 8.16e-10 | 160 | 231 | 11 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TCERG1L ADGRV1 FREM1 RYR2 CIITA COL12A1 MUC19 RPSA FCRLA HMCN1 LRP2 | 2.24e-09 | 176 | 231 | 11 | c6484334187f64cd00cd35e77d8ae436556b4260 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.10e-09 | 199 | 231 | 11 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.17e-08 | 170 | 231 | 10 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.93e-08 | 181 | 231 | 10 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | TMEM215 ZNF469 HMCN2 PTPRD PLOD2 COL12A1 HMCN1 ROBO1 ROBO2 ARMH4 | 4.59e-08 | 184 | 231 | 10 | 0b336489c10e8c3c957795dd845454f03404382b |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.35e-08 | 187 | 231 | 10 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 5.35e-08 | 187 | 231 | 10 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 6.21e-08 | 190 | 231 | 10 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.20e-08 | 193 | 231 | 10 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.20e-08 | 193 | 231 | 10 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.20e-08 | 193 | 231 | 10 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.20e-08 | 193 | 231 | 10 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 7.93e-08 | 195 | 231 | 10 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.72e-08 | 197 | 231 | 10 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 8.72e-08 | 197 | 231 | 10 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.72e-08 | 197 | 231 | 10 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.15e-08 | 198 | 231 | 10 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.59e-08 | 199 | 231 | 10 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.00e-07 | 200 | 231 | 10 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.00e-07 | 200 | 231 | 10 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.00e-07 | 200 | 231 | 10 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-07 | 200 | 231 | 10 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-07 | 200 | 231 | 10 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.00e-07 | 200 | 231 | 10 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-07 | 200 | 231 | 10 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.00e-07 | 200 | 231 | 10 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.00e-07 | 200 | 231 | 10 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.00e-07 | 200 | 231 | 10 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-07 | 160 | 231 | 9 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-07 | 183 | 231 | 9 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.32e-07 | 184 | 231 | 9 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.57e-07 | 185 | 231 | 9 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.82e-07 | 186 | 231 | 9 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 6.66e-07 | 189 | 231 | 9 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-07 | 190 | 231 | 9 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-07 | 191 | 231 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | critical-Lymphoid-B_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.27e-07 | 191 | 231 | 9 | 0716cfaeb11d9c90c18fa8f9d50c9c6fb5182848 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.60e-07 | 192 | 231 | 9 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.60e-07 | 192 | 231 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.93e-07 | 193 | 231 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 7.93e-07 | 193 | 231 | 9 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | HLA-DPA1 ARID1B CIITA MARCHF1 RAPGEF1 FCRLA CR1 SETBP1 SNX22 | 8.28e-07 | 194 | 231 | 9 | ff661419b697aef51a53fdeac8d37d870d65f491 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.64e-07 | 195 | 231 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | ASK428-Endothelial-Endothelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.02e-07 | 196 | 231 | 9 | b1a81eddb91fb462360692b7b0a3ba4a947eac40 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.02e-07 | 196 | 231 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 9.02e-07 | 196 | 231 | 9 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 9.02e-07 | 196 | 231 | 9 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.41e-07 | 197 | 231 | 9 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 9.81e-07 | 198 | 231 | 9 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.02e-06 | 199 | 231 | 9 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.02e-06 | 199 | 231 | 9 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-06 | 200 | 231 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.07e-06 | 200 | 231 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.07e-06 | 200 | 231 | 9 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-06 | 200 | 231 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-06 | 200 | 231 | 9 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-06 | 200 | 231 | 9 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-06 | 200 | 231 | 9 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-06 | 200 | 231 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.07e-06 | 200 | 231 | 9 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 156 | 231 | 8 | 0695ac0f02d059ecf813d61d3c9d4c76d1d85834 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 156 | 231 | 8 | 1c2920f4356789a9c11d5ea1eaafb18a50b19ed7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 156 | 231 | 8 | a45fbe02cd03bd4a097f21368bc1179779ba0db8 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-06 | 160 | 231 | 8 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 161 | 231 | 8 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 161 | 231 | 8 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.81e-06 | 168 | 231 | 8 | c51244b4bdbfd961e2725306aa9cb25dd66d58bd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 168 | 231 | 8 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-06 | 172 | 231 | 8 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-06 | 174 | 231 | 8 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.64e-06 | 174 | 231 | 8 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | TCERG1L COL22A1 SLC8B1 PTPRD MARCHF1 COL12A1 KIAA1549 SPHKAP | 3.64e-06 | 174 | 231 | 8 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.80e-06 | 175 | 231 | 8 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.80e-06 | 175 | 231 | 8 | d544f24ee33783ed4afb4d7ec079a4484118bb15 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 4.49e-06 | 179 | 231 | 8 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.68e-06 | 180 | 231 | 8 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.68e-06 | 180 | 231 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-06 | 180 | 231 | 8 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.88e-06 | 181 | 231 | 8 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.05e-06 | 129 | 231 | 7 | 454bae525f6db3d0dd6347d2a2c3ea9dda9cd212 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.08e-06 | 182 | 231 | 8 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.08e-06 | 182 | 231 | 8 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.08e-06 | 182 | 231 | 8 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.29e-06 | 183 | 231 | 8 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-06 | 183 | 231 | 8 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-06 | 183 | 231 | 8 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-06 | 183 | 231 | 8 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.73e-06 | 185 | 231 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.96e-06 | 186 | 231 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 6.20e-06 | 187 | 231 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 6.20e-06 | 187 | 231 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.44e-06 | 188 | 231 | 8 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| Disease | Malignant neoplasm of breast | EPHB4 XIRP1 BCORL1 LRRC37A2 OBSCN HLCS DYSF EOMES FASN ARID1B LRRC37A CLCN1 PTPRD DLEC1 PLOD1 PGBD3 FN1 PCDHGB6 TACC2 CSF1 SIPA1L1 SETBP1 ROBO1 USP54 PRRT1 EP300 | 2.08e-07 | 1074 | 224 | 26 | C0006142 |
| Disease | cortical thickness | ADGRV1 DYSF TENM2 PLEKHM1 STAB1 ZNF469 ARID1B PTPRF TNRC6A IGSF9 TACC1 DLEC1 COL12A1 ESPNL RPSA TACC2 RAB44 ITIH5 SHF VCAN ROBO1 ROBO2 ULK2 | 1.47e-05 | 1113 | 224 | 23 | EFO_0004840 |
| Disease | cortical surface area measurement | SPRY2 COL22A1 ADGRV1 DYSF TENM2 PLEKHM1 ZNF469 ARID1B CLCN2 PTPRF TNRC6A IGSF9 TACC1 TANGO6 TUT7 RPSA FRYL CRKL ITIH5 VCAN MDC1 ROBO1 ROBO2 PRRT1 TNXB | 3.59e-05 | 1345 | 224 | 25 | EFO_0010736 |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 5.74e-05 | 2 | 224 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 5.74e-05 | 2 | 224 | 2 | cv:C4551859 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 5.74e-05 | 2 | 224 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Menke-Hennekam syndrome | 5.74e-05 | 2 | 224 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 5.74e-05 | 2 | 224 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 5.74e-05 | 2 | 224 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 5.74e-05 | 2 | 224 | 2 | C4551859 | |
| Disease | choroideremia (implicated_via_orthology) | 5.74e-05 | 2 | 224 | 2 | DOID:9821 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 5.74e-05 | 2 | 224 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 5.74e-05 | 2 | 224 | 2 | C0035934 | |
| Disease | Squamous cell carcinoma of esophagus | 8.86e-05 | 95 | 224 | 6 | C0279626 | |
| Disease | intracranial aneurysm (is_implicated_in) | 9.03e-05 | 12 | 224 | 3 | DOID:10941 (is_implicated_in) | |
| Disease | Familial vesicoureteral reflux | 1.71e-04 | 3 | 224 | 2 | cv:C4706552 | |
| Disease | hereditary hemorrhagic telangiectasia (implicated_via_orthology) | 1.71e-04 | 3 | 224 | 2 | DOID:1270 (implicated_via_orthology) | |
| Disease | Familial vesicoureteral reflux | 1.71e-04 | 3 | 224 | 2 | C4706552 | |
| Disease | Telangiectasia, Hereditary Hemorrhagic, Type 1 | 1.71e-04 | 3 | 224 | 2 | C4551861 | |
| Disease | Vesicoureteral reflux | 1.71e-04 | 3 | 224 | 2 | cv:C0042580 | |
| Disease | response to anti-tuberculosis drug, drug-induced liver injury | 1.71e-04 | 3 | 224 | 2 | EFO_0004228, EFO_0007918 | |
| Disease | Malignant mesothelioma | 1.89e-04 | 109 | 224 | 6 | C0345967 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 2.09e-04 | 71 | 224 | 5 | EFO_0007878, EFO_0007979 | |
| Disease | Colorectal Carcinoma | EPHB6 TCERG1L OBSCN ZNF232 PTPRD PZP FN1 AKAP3 CORO1B ARNT RPAP1 GUCY2C SETBP1 LRP2 EP300 | 3.33e-04 | 702 | 224 | 15 | C0009402 |
| Disease | Fanconi syndrome (implicated_via_orthology) | 3.41e-04 | 4 | 224 | 2 | DOID:1062 (implicated_via_orthology) | |
| Disease | Vesico-Ureteral Reflux | 3.41e-04 | 4 | 224 | 2 | C0042580 | |
| Disease | hereditary hemorrhagic telangiectasia (is_implicated_in) | 3.41e-04 | 4 | 224 | 2 | DOID:1270 (is_implicated_in) | |
| Disease | Hereditary hemorrhagic telangiectasia | 3.41e-04 | 4 | 224 | 2 | cv:C0039445 | |
| Disease | Hereditary hemorrhagic telangiectasia | 3.41e-04 | 4 | 224 | 2 | C0039445 | |
| Disease | glomerulonephritis (is_marker_for) | 3.82e-04 | 19 | 224 | 3 | DOID:2921 (is_marker_for) | |
| Disease | QRS duration | 4.87e-04 | 298 | 224 | 9 | EFO_0005055 | |
| Disease | lung carcinoma (is_marker_for) | 5.65e-04 | 5 | 224 | 2 | DOID:3905 (is_marker_for) | |
| Disease | vesicoureteral reflux (is_implicated_in) | 5.65e-04 | 5 | 224 | 2 | DOID:9620 (is_implicated_in) | |
| Disease | muscular disease (implicated_via_orthology) | 5.65e-04 | 5 | 224 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | Renal glomerular disease | 6.83e-04 | 23 | 224 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 6.83e-04 | 23 | 224 | 3 | C4521256 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 7.07e-04 | 53 | 224 | 4 | C4707243 | |
| Disease | arteriovenous malformations of the brain (implicated_via_orthology) | 1.17e-03 | 7 | 224 | 2 | DOID:0060688 (implicated_via_orthology) | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 1.17e-03 | 7 | 224 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | Bleeding tendency | 1.17e-03 | 7 | 224 | 2 | C1458140 | |
| Disease | common variable immunodeficiency | 1.17e-03 | 7 | 224 | 2 | MONDO_0015517 | |
| Disease | Disorder of eye | 1.23e-03 | 212 | 224 | 7 | C0015397 | |
| Disease | Craniofacial Abnormalities | 1.26e-03 | 156 | 224 | 6 | C0376634 | |
| Disease | smoking status measurement | TMOD2 PFKM TENM2 RYR2 STAB1 SALL1 PTPRD PTPRF TNRC6A DLEC1 PRRC2B BICRA HECTD4 CSF1 SETBP1 TTL ROBO2 MDGA1 ARMH4 | 1.45e-03 | 1160 | 224 | 19 | EFO_0006527 |
| Disease | Familial pulmonary arterial hypertension | 1.56e-03 | 8 | 224 | 2 | C1701939 | |
| Disease | neutropenia (is_implicated_in) | 1.56e-03 | 8 | 224 | 2 | DOID:1227 (is_implicated_in) | |
| Disease | cognitive function measurement, self reported educational attainment | 1.66e-03 | 355 | 224 | 9 | EFO_0004784, EFO_0008354 | |
| Disease | conotruncal heart malformations | 1.81e-03 | 114 | 224 | 5 | MONDO_0016581 | |
| Disease | hematocrit | HIVEP1 BCORL1 HLCS ADGRV1 PFKM ACVRL1 STAB1 ARID1B SALL1 HECTD4 EPB41L5 CR1 SUSD1 LINGO4 LRP2 NUMB ENG | 1.95e-03 | 1011 | 224 | 17 | EFO_0004348 |
| Disease | sleep apnea measurement | 1.95e-03 | 116 | 224 | 5 | EFO_0007817 | |
| Disease | joint hypermobility measurement | 1.99e-03 | 33 | 224 | 3 | EFO_0007905 | |
| Disease | interleukin 18 receptor accessory protein measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0008179 | |
| Disease | interleukin-36 alpha measurement | 1.99e-03 | 9 | 224 | 2 | EFO_0021851 | |
| Disease | serum albumin measurement | HIVEP1 ADGRV1 DYSF PLEKHM1 BBX CIITA MIPEP NPHS1 EPB41L5 ARNT CSF1 CSNK1G3 | 2.02e-03 | 592 | 224 | 12 | EFO_0004535 |
| Disease | Intellectual Disability | 2.33e-03 | 447 | 224 | 10 | C3714756 | |
| Disease | cerebral palsy (implicated_via_orthology) | 2.48e-03 | 10 | 224 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | cystic kidney disease (implicated_via_orthology) | 2.48e-03 | 10 | 224 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | glucagon-like peptide-1 measurement | 2.48e-03 | 10 | 224 | 2 | EFO_0008465 | |
| Disease | Fanconi anemia (is_implicated_in) | 2.48e-03 | 10 | 224 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | behavioural disinhibition measurement | 2.58e-03 | 75 | 224 | 4 | EFO_0006946 | |
| Disease | Breast Carcinoma | EPHB4 LRRC37A2 FASN ARID1B LRRC37A PTPRD FN1 PCDHGB6 CSF1 SETBP1 EP300 | 2.88e-03 | 538 | 224 | 11 | C0678222 |
| Disease | urate measurement, bone density | PEX14 COL6A5 TENM2 FREM1 SALL1 PTPRD MIPEP MARCHF1 NUP153 PRRC2B ROBO1 TNXB | 2.90e-03 | 619 | 224 | 12 | EFO_0003923, EFO_0004531 |
| Disease | white matter microstructure measurement | 3.11e-03 | 390 | 224 | 9 | EFO_0005674 | |
| Disease | red blood cell density measurement | RAB11B HIVEP1 ADGRV1 PFKM ACVRL1 ARID1B SALL1 PTPRF CEP78 CIITA EPB41L5 KIF4B FYB1 ENG ARMH4 | 3.13e-03 | 880 | 224 | 15 | EFO_0007978 |
| Disease | small cell lung carcinoma | 3.26e-03 | 80 | 224 | 4 | EFO_0000702 | |
| Disease | Nonsyndromic Deafness | 3.41e-03 | 81 | 224 | 4 | C3711374 | |
| Disease | post-traumatic stress disorder symptom measurement | 3.56e-03 | 82 | 224 | 4 | EFO_0008535 | |
| Disease | Hodgkins lymphoma | 3.56e-03 | 82 | 224 | 4 | EFO_0000183 | |
| Disease | cystatin C measurement | 3.79e-03 | 402 | 224 | 9 | EFO_0004617 | |
| Disease | asthma, response to diisocyanate | 3.94e-03 | 261 | 224 | 7 | EFO_0006995, MONDO_0004979 | |
| Disease | juvenile rheumatoid arthritis (is_implicated_in) | 4.24e-03 | 13 | 224 | 2 | DOID:676 (is_implicated_in) | |
| Disease | serum gamma-glutamyl transferase measurement | TENM2 FCHO1 RYR2 STAB1 SALL1 MED13 BICRA HECTD4 FCRLA PDHX CSNK1G3 ROBO1 PPP6R2 PIWIL3 MAST3 | 4.43e-03 | 914 | 224 | 15 | EFO_0004532 |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 4.92e-03 | 14 | 224 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | 2-oxo-hept-3-ene-1,7-dioate hydratase activity | 4.92e-03 | 14 | 224 | 2 | C1150929 | |
| Disease | nevus count, cutaneous melanoma | 5.16e-03 | 91 | 224 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | response to olanzapine | 5.64e-03 | 15 | 224 | 2 | GO_0097333 | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 5.64e-03 | 15 | 224 | 2 | C2930967 | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 5.81e-03 | 48 | 224 | 3 | C4551993 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 5.81e-03 | 48 | 224 | 3 | C1862941 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 6.15e-03 | 49 | 224 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | cleft lip | 6.20e-03 | 284 | 224 | 7 | EFO_0003959 | |
| Disease | decreased susceptibility to hepatitis C infection | 6.42e-03 | 16 | 224 | 2 | EFO_0010101 | |
| Disease | Blood Coagulation Disorders | 6.42e-03 | 16 | 224 | 2 | C0005779 | |
| Disease | Abnormal behavior | 6.42e-03 | 16 | 224 | 2 | C0233514 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 6.51e-03 | 50 | 224 | 3 | C1862939 | |
| Disease | worry measurement | 6.54e-03 | 154 | 224 | 5 | EFO_0009589 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 7.08e-03 | 157 | 224 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | Mammary Carcinoma, Human | EPHB4 LRRC37A2 FASN LRRC37A PTPRD FN1 PCDHGB6 CSF1 SETBP1 EP300 | 7.14e-03 | 525 | 224 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | EPHB4 LRRC37A2 FASN LRRC37A PTPRD FN1 PCDHGB6 CSF1 SETBP1 EP300 | 7.14e-03 | 525 | 224 | 10 | C1257931 |
| Disease | Adenoid Cystic Carcinoma | 7.18e-03 | 100 | 224 | 4 | C0010606 | |
| Disease | Familial primary pulmonary hypertension | 7.24e-03 | 17 | 224 | 2 | C0340543 | |
| Disease | Mammary Neoplasms | EPHB4 LRRC37A2 FASN LRRC37A PTPRD FN1 PCDHGB6 CSF1 SETBP1 EP300 | 7.32e-03 | 527 | 224 | 10 | C1458155 |
| Disease | neurotic disorder | 7.44e-03 | 101 | 224 | 4 | EFO_0004257 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPTDPVARDGPLSQT | 366 | O75410 | |
| APPVTIVQPSASAGQ | 606 | P27540 | |
| PDAGPSQVTTFLTVP | 231 | Q5W0A0 | |
| GLLSPQQSEEVANPP | 501 | O95936 | |
| SQPAVSIEGQVSNPP | 941 | Q09472 | |
| LRNQGETPTTEVPAP | 556 | Q9UJX2 | |
| VIPEPSPTSQTIQEG | 356 | P41214 | |
| QEDPQFSVPPTANTP | 271 | Q5VTM2 | |
| IFNTPEPTTTQEPLV | 806 | Q8WY36 | |
| IPTEFPPVGNIVSFE | 391 | P13611 | |
| VNPVEFNTEVATPPF | 3046 | P13611 | |
| NPSPELGDISITPVQ | 326 | A6NCI8 | |
| NLPEGPIQFVPTIST | 221 | P33076 | |
| VTGPNEEFTPVLGSP | 546 | Q86TY3 | |
| FLTGIPPFNDETPQQ | 771 | Q96GX5 | |
| SFQPGTVLTPSQPLV | 436 | Q5H9F3 | |
| DFIDLQPNTTVVFPP | 321 | Q8WXG9 | |
| SLGTPQEVVEAPETP | 341 | Q7L3V2 | |
| AETNSQQPGPDVPVL | 981 | Q92793 | |
| TVFPKEPVELGQPNT | 121 | P20036 | |
| QIPENGLTSPLTEPV | 111 | Q9BR76 | |
| LVLEATQPPSEQPGT | 101 | P37023 | |
| ITFPPGSVEASQPVL | 1676 | Q8NFD5 | |
| AEAQDPFPTVGPNSV | 2131 | Q8NFD5 | |
| LQQPGFPVTVTVESP | 416 | Q5JTW2 | |
| IPENTPVGTPIFIVN | 141 | Q9H251 | |
| PVGTPIFIVNATDPD | 146 | Q9H251 | |
| AGNPPLNSTVPVTIE | 646 | Q9H251 | |
| NLSNLEEFPPVGSVP | 171 | Q8IWY9 | |
| TFQEPPGVNTTELPS | 126 | P17813 | |
| QVVPAESSSPQGPLT | 81 | P36575 | |
| TVPSSEAGIQPVPVQ | 396 | Q6HA08 | |
| TTQPAVEPTDGCFIP | 281 | Q9Y4P1 | |
| QISILTVPAEEPGTF | 471 | P24386 | |
| DQQTSILIVPPAEPG | 471 | P26374 | |
| EVPSSNGEIPPFTQR | 386 | O75901 | |
| PGNNVVDISVPPTTD | 191 | Q15907 | |
| VIPLNNEQSSGPVPE | 721 | P20742 | |
| NVSPVPGFQPQDESL | 251 | P69849 | |
| PSATPQAQVEAEGPT | 721 | Q7Z6P3 | |
| LQPVPADVVSSQGVP | 36 | Q6PCD5 | |
| SQGVPSILQPAPAEV | 46 | Q6PCD5 | |
| IPPENIFPLETNETN | 471 | P25092 | |
| APTQPSEGAQRVVTP | 426 | O60393 | |
| PPGSPVLQVTATDQD | 256 | Q9Y5F9 | |
| VQTVLQFVPPSVDTG | 1046 | Q9HCM3 | |
| QPDQPDIPITSFVSL | 501 | Q14207 | |
| PAEPFTGELPAQQTL | 971 | O00763 | |
| SNGSFLAPETEPIVP | 391 | Q9H1A4 | |
| VQLNVQFPPEVEPSS | 531 | Q8NFP4 | |
| PGAPSLSFTVQVAEP | 1251 | O75147 | |
| SLPIPEDAQPGTVIT | 356 | Q9UN72 | |
| PGATAVPTPLTNVQI | 776 | O14526 | |
| REIETGPTNIQSTPP | 1616 | Q8WXI7 | |
| TEIPVDIITPFNASP | 10221 | Q8WXI7 | |
| VPPQATTFTLTGLQP | 991 | O60500 | |
| TPQRETVTPGPNFQE | 271 | Q9NP74 | |
| PIPENAPETVVALFS | 356 | Q9Y5F0 | |
| SAEASEVAPGVQPLP | 576 | Q6ZVH7 | |
| NVSPVPGFQPQDESL | 251 | Q5JPE7 | |
| PLAVQQETSFQSPEP | 471 | O60309 | |
| PPIQSTAGAVPVRNE | 11 | P55081 | |
| DQPVTPEPTSQATRG | 1421 | Q14676 | |
| FGIPQEPQREPPTTS | 56 | O15481 | |
| TQSPFEGFPQSPLQI | 186 | O60732 | |
| EGFPQSPLQIPVSRS | 191 | O60732 | |
| EGFAQSPLQIPVSPS | 226 | O60732 | |
| PTVFGNLPTDPEVTQ | 81 | P17735 | |
| PLAVQQETSFQSPEP | 471 | A6NM11 | |
| PLAVQQETSFQSPEP | 471 | A6NMS7 | |
| ATGPVPFEPVNVTTD | 416 | P54760 | |
| PFLVAVENGSAPSEP | 196 | Q5TGJ6 | |
| GPPPSTVINQNETFA | 221 | Q86UX2 | |
| APQVPLDGADTSVFP | 536 | Q7L2J0 | |
| TVQPSPFPEGTASNV | 526 | O95835 | |
| GLFSQPVPAVPVSSI | 111 | Q15742 | |
| AISVPQSPFLGQQEP | 481 | Q8IYA8 | |
| PAPNVTVSPGETAVL | 521 | Q8NDA2 | |
| SNVEFQPFEPLQPSV | 946 | Q6DN90 | |
| GITPNIQLEDFPTSP | 2841 | Q2LD37 | |
| QTPVETNEFPQLPEG | 2956 | Q2LD37 | |
| ELPPSSNIVQTPEDF | 336 | P50747 | |
| PVQVPGPVAASTEAL | 466 | Q9UIS9 | |
| PGQPNAVGTFTEIPA | 266 | O00330 | |
| TAGVPTRPQVSQPET | 8121 | Q7Z5P9 | |
| AIPENTNIGSLFPIP | 176 | Q08174 | |
| PFVVIPATVSNNVPG | 521 | P08237 | |
| VPPSGTIQVTLFNPN | 951 | Q32MH5 | |
| EQDGFPEVQTSPLPS | 2651 | O94915 | |
| PSVEDGFQTVPLITP | 16 | Q9Y328 | |
| APLGTFQPDPATIQQ | 186 | Q9H4M3 | |
| GPTPPTSENEQKQAF | 156 | O15117 | |
| TVYPVDNQPPSIAIG | 1016 | Q5H8C1 | |
| DNQPPSIAIGPVFVV | 1021 | Q5H8C1 | |
| PFSIIINPTNDEAPD | 1136 | Q5H8C1 | |
| VPQQPEQVLSSGSPA | 896 | Q14005 | |
| NVSPVPGFQPQDESL | 251 | Q15155 | |
| DNVPVTVPVGLNLPS | 1116 | P50748 | |
| NYGSPINPSEIVPET | 4551 | P98164 | |
| VRATDPQQVAFPSPA | 321 | Q92985 | |
| AITPLPSTQNGPVFA | 226 | P46109 | |
| SIGPPVESINPETVS | 1606 | Q9Y4D8 | |
| PTPVGAVQQDPALSS | 331 | Q9Y6M4 | |
| PVPNFGDITTVTFPV | 411 | Q8IZQ8 | |
| VPVPQTGANSLPSAE | 266 | Q8TCQ1 | |
| PQSTGSEVEENPPFQ | 776 | Q9Y5F1 | |
| PNVSIGVFIEQPTPF | 296 | O00469 | |
| PTVLVGVFIEQPTPF | 286 | Q02809 | |
| QTFFDVSEPPPVIQV | 511 | Q96RW7 | |
| TLDVGSPPVFIQEPA | 786 | Q96RW7 | |
| PPTIIGTNFPNEVSV | 1451 | Q96RW7 | |
| IQVPPSVAGAEIPSD | 3241 | Q96RW7 | |
| SPEFVSPEIIQQNPV | 6626 | Q5VST9 | |
| NTPFQLSIAPPEAEG | 181 | Q8NI37 | |
| QPVFNLTVSAENPDP | 771 | Q9BYE9 | |
| VPVEIENLPQSPGTD | 426 | Q9HCM4 | |
| NVQQTTDLEIPPPGT | 1786 | Q9ULT8 | |
| EFSPVVNSQILPPEE | 841 | Q6WRI0 | |
| PISPPFTQRAVTDNV | 1476 | Q6WRI0 | |
| SVLEPPGFASQPQVT | 696 | Q8N9C0 | |
| EASEIPVPQGTELSP | 311 | P09603 | |
| SPTIPINDFEFPVGT | 1406 | P17927 | |
| TVFVQTPNLEGPGVS | 2271 | Q99715 | |
| LTSYGTPIQPQTVDP | 311 | Q9NZD1 | |
| TPIQPQTVDPTQECF | 316 | Q9NZD1 | |
| PEQASEPQVAFTPSQ | 146 | Q9P218 | |
| SEEPPQAGVQEPTAT | 71 | H7BZ55 | |
| DQVFPNGTLAPSIPI | 3026 | Q9Y6R7 | |
| NDQVFPNGTLAPSIP | 4226 | Q9Y6R7 | |
| IFQSPGPGIPETASV | 146 | Q7L513 | |
| PVEVFITETPSQPNS | 611 | P02751 | |
| QPGSSIPPYNTEVTE | 1086 | P02751 | |
| SLSPVIPGFPQIVNS | 51 | Q6ZTQ4 | |
| IPGFPQIVNSNPLTE | 56 | Q6ZTQ4 | |
| AGLPEVSLNVDTPFP | 566 | Q6UUV7 | |
| SQAVPAVTEGPIPEV | 56 | P07339 | |
| SNIVDDNGLIPPTPI | 1726 | O75417 | |
| GFDNTGTFQVIPVPP | 1911 | A8TX70 | |
| SPEVNLNVPVQVSFP | 3366 | Q8N3K9 | |
| PGTPIQFDIVLPATE | 446 | Q8NEU8 | |
| PVVQSTEDVFPQGLP | 276 | Q8NFW1 | |
| PVPPVSTVTGDENIS | 371 | Q9HAW0 | |
| PPNGEPVAQFSITTP | 491 | Q6ZN28 | |
| QFEEPPLGAQTPRAT | 41 | Q8N5U1 | |
| TQRTGVITSPDFPNP | 191 | P48740 | |
| EPQEEATGLPTSVPQ | 1276 | O60307 | |
| DPTEVTPGLSFFNPV | 1146 | Q2VIQ3 | |
| ELPDEVVVPPGVTNS | 71 | O60931 | |
| ALPQQPSEDVVSSGP | 581 | Q8NBF1 | |
| GFQGTEVTTLVQPPP | 116 | Q6ZRV2 | |
| TPNPTEPLFLAQAEV | 976 | P49327 | |
| ATGEAAPVLTVQPAP | 611 | Q9NZM4 | |
| PAPIGEFQSTEPEQS | 351 | Q9Y238 | |
| NFQNPPPGTVIDVEL | 776 | Q7Z3Z3 | |
| APAQTAQAPGFVVPT | 136 | Q99946 | |
| TTNIQPVGTPFEELP | 116 | O75056 | |
| SPPQEVFVGEAVPTA | 1611 | Q58EX2 | |
| VLIVNENPASPPETF | 71 | Q9NSC2 | |
| VFPSPLPNIGTTAED | 401 | Q9NSC2 | |
| FNPQPVDTSNITIPE | 2701 | Q92736 | |
| EPVPEFTLNPNFTIV | 526 | Q9ULB4 | |
| FQSDPQEPETPSPGI | 111 | Q52MB2 | |
| FGEPATVAEQPPSIV | 1211 | O75923 | |
| SVNVGPLASQPVFSP | 176 | O75364 | |
| GFTPELESIIPVPSN | 16 | Q8NE79 | |
| TANTVPPTQPFLEGG | 126 | Q8IY42 | |
| SSEEQVGARVPPTPN | 96 | Q9BUF7 | |
| VFDEPANSTPTAPGV | 716 | O75170 | |
| VIQVEPPNGTLSDPN | 501 | Q6UY18 | |
| FTAVGDGPPSPTIQV | 491 | P10586 | |
| LDGPEPSIEVFQPSN | 106 | Q2NL67 | |
| RGPPSEPVLTQTSEQ | 401 | P23468 | |
| ISIPEEVPTGFPQNL | 911 | P23468 | |
| ISPQFPASGVNQTPV | 36 | Q6J4K2 | |
| PIPENAPETVVALFS | 356 | Q9UN66 | |
| SVTTAVPENFPPGTI | 351 | Q9Y5H4 | |
| DDFLSPVGVPESTPQ | 661 | Q6ZRI0 | |
| PVGVPESTPQLFGNS | 666 | Q6ZRI0 | |
| VQPVAGRVTAPPNDF | 121 | Q8N328 | |
| AFLTSQPVPVGVVPA | 486 | P49757 | |
| GVVPALQPAFVPAQS | 496 | P49757 | |
| PVFLGEPVSPQTLAA | 121 | P30711 | |
| QEAPFSGISTPPDVL | 1071 | Q96Q06 | |
| VPTNGLSQETEIPTP | 321 | Q9Y4G2 | |
| GVQVPSVPIQQFPTE | 251 | P08865 | |
| EPLGVFPTQGTPVAS | 721 | O95197 | |
| SEEFPVPPAVLQQTF | 181 | Q9H9J2 | |
| VFIPPDIQTPESSSV | 151 | Q9BSD3 | |
| VVVQSPDGSDAAPQP | 451 | Q2M3C7 | |
| QVQVPTPARDSAGVP | 21 | Q7Z2T5 | |
| SQTVPEPDQGPVSQP | 771 | P52630 | |
| SPEEPVGAPAVQSIL | 976 | Q24JP5 | |
| FAGPPVTAQPIISED | 901 | Q14596 | |
| QAVNGVSELSPDPPQ | 461 | O15197 | |
| VTIVFQEPGAQPFSP | 711 | O43166 | |
| VEENTFVGPPPATSI | 116 | Q8NDZ2 | |
| GSSQPAVLQPSVEPT | 56 | O15127 | |
| SAAPGQNPIVPETQV | 1041 | Q9NT68 | |
| NGEIVETTNIVAPPP | 1451 | Q13017 | |
| QPPITPDVETFQNTV | 326 | P40879 | |
| QGPTSAPILFPVTEE | 36 | Q9UHV7 | |
| EPSSLGPATQVVPVQ | 76 | O75381 | |
| QDEEQPTPSGFEPTV | 681 | Q7RTU9 | |
| PNVTVAPDSSQGPIV | 131 | Q8N0Z3 | |
| NTNEYTEGPTVVPRP | 51 | O43597 | |
| VEAAGTTNFPANEPP | 551 | O75969 | |
| QEDPQFSVPPTANTP | 226 | A6NIR3 | |
| EAPEPAGQRPSIFQS | 756 | P35523 | |
| PPTPEASVCFQVNTE | 666 | P51788 | |
| VDPENLRGPSPSSVQ | 251 | Q5VWI1 | |
| VLGQNSPPFSSVPEI | 381 | Q7M4L6 | |
| VDSQAPNTGVPVAQP | 701 | A6PVC2 | |
| TIPETPGPQFSQQRE | 96 | Q9H171 | |
| PPPQSQGEVSVASSI | 121 | Q68D42 | |
| CSTPPGPQTVLIFDE | 96 | Q99797 | |
| LETTPVPQESGPNTQ | 186 | Q8NDY8 | |
| PEFVAPEIVNQSPVS | 1761 | Q15772 | |
| FSGVDSVQELAPPPA | 596 | Q13905 | |
| VTVLQTNPNPVFESP | 81 | Q9HAI6 | |
| QVSEPVNPELSAGPI | 261 | Q9BSJ1 | |
| TQITEPPLPEVEFFT | 581 | Q6UWL2 | |
| GVTAPQQEETPPATE | 1456 | P22105 | |
| AQPVEATGVPVDPST | 146 | Q8IY51 | |
| PVVQSPPGTEANFSA | 181 | Q9H8N7 | |
| SNAPIIPQGVNEPST | 811 | Q9C0B7 | |
| SIIDEFLQQAPPPGV | 741 | Q9HBJ7 | |
| TFPEEAPTVSPAVAQ | 586 | Q5JSZ5 | |
| NPTLVSVPNPVFGSD | 2531 | Q9NY15 | |
| DPVRTQDISPPAQGV | 611 | Q9HCK4 | |
| PAAQIPIAVEEPGSS | 426 | O95359 | |
| LEEAPSAPPQGVTVS | 771 | Q9Y6N7 | |
| IVIPTNFCSPDGQPT | 416 | Q9H0V1 | |
| PPVATFVFGQSSNPV | 1221 | P49790 | |
| SVAVNLPVPSGVAFP | 116 | Q9BWH6 | |
| TVNSPPQFQETPPAV | 131 | Q9P2J2 | |
| PINTPTAAVDQTLFP | 421 | Q9NNW5 | |
| PSPESLPNVVVNGVL | 151 | Q96L94 | |
| AVTAVPTEPPTLQGA | 2316 | Q96JG9 | |
| SPSPLVGTIPEQFSQ | 476 | Q8IYT8 | |
| QVSEPVNPEFSAGPI | 261 | A0A3B3IT33 | |
| SAVPLSQGQVVVSPP | 366 | O95789 | |
| PQPPITEVESQVFSE | 206 | Q9UNY5 | |
| QDEEQPTPSGFEPTV | 681 | A6NGW2 | |
| NGPSVPSEEEIVQPL | 946 | Q5VWN6 | |
| PNLALPEETFVSGPQ | 281 | Q96LX8 | |
| IPLQPVLPGTQASED | 906 | P52746 | |
| PPTPSQINAVGIAID | 286 | Q5VYS8 | |
| PDVPAVPSNFQSLVA | 756 | Q9Y6X0 | |
| PQEFIATQGPLPQTV | 886 | Q9HD43 | |
| SSVFPPPDVEQPQTQ | 356 | Q8NG68 | |
| STTVTEQAEPPRNPG | 1786 | Q702N8 | |
| FEEPPNPTNVEISLQ | 176 | Q9NZR1 | |
| DDVFVSGPNAPVPQS | 876 | P15822 | |
| PETDPYVTPGSVINN | 1626 | Q8NDV7 | |
| NSNPDSPVNFEVIPV | 71 | P0DTE5 | |
| GTVVRISPQDFPQNP | 106 | P17097 | |
| PVSTQDLPPQAEFQS | 356 | Q70EL1 | |
| PEPISGGVPFQSVLV | 1846 | E9PAV3 |